secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001860742-24-000016
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q3 revenue $1.196B (+19% YoY); raises FY2024 revenue guidance
---------------------------------------------------------------------------

- GAAP net income $4M vs net loss of $84M YoY; adjusted EPS $0.13 ($0.17 ex-IPR&D).
- Adjusted EBITDA $212M ($227M ex-IPR&D) vs $187M YoY, driven by broad-based sales growth.
- Pharmaceuticals revenue surged 76% to $306M on XIIDRA acquisition and MIEBO launch.
- FY2024 revenue guidance raised to $4.725-4.825B (prior $4.70-4.80B); adjusted EBITDA outlook unchanged.
- Cash flow from operations $154M, up from $48M YoY, aided by gross profit and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000016/0001860742-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000016/blco-20241030.htm
  HTML page:      https://secwatch.observer/filing/0001860742-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer